The much-awaited Gujarat Kidney and Super Speciality IPO has entered its final day of bidding on 24 December 2025, drawing strong interest from retail and non-institutional investors. With growing subscription numbers and a positive grey market sentiment, this healthcare IPO has become a key topic among stock market participants.
In this blog, we cover Day 3 subscription status, latest GMP, issue details, business overview, utilisation of funds, and key takeaways to help investors make an informed decision.
Gujarat Kidney and Super Speciality IPO: Key Highlights
| Particulars | Details |
|---|---|
| IPO Size | ₹250.80 crore |
| Issue Type | Book-building (100% Fresh Issue) |
| Shares Offered | 2.20 crore shares |
| Price Band | ₹108 – ₹114 per share |
| Lot Size | 128 shares |
| Minimum Retail Investment | ₹14,592 |
| Lead Manager | Nirbhay Capital Services Pvt. Ltd. |
| Registrar | MUFG Intime India Pvt. Ltd. |
| Listing Date | 30 December 2025 |
| Exchanges | NSE & BSE |
Gujarat Kidney and Super Speciality IPO Subscription Status (Day 3)
As of 25 December 2025 at 10:51 AM, the IPO witnessed healthy demand across investor categories.
📊 Category-wise Subscription
| Investor Category | Subscription (Times) |
|---|---|
| Qualified Institutional Buyers (QIBs) | 0.35x |
| Non-Institutional Investors (NIIs) | 3.59x |
| Retail Individual Investors (RIIs) | 12.82x |
| Total Subscription | 3.23x |
🔍 What Does This Mean?
- Retail investors show strong confidence, subscribing nearly 13 times.
- NIIs have also shown solid participation.
- QIB participation remains moderate, which is common in healthcare-focused IPOs with long-term growth potential.
Gujarat Kidney and Super Speciality IPO GMP Today
According to market sources, the Grey Market Premium (GMP) for Gujarat Kidney and Super Speciality IPO stands at ₹2.5 per share.
📈 GMP Insight
- A positive GMP indicates moderate listing expectations.
- GMP is not guaranteed and can change based on market sentiment.
- Investors should use GMP as an additional indicator, not the sole basis for investment decisions.
Utilisation of IPO Proceeds: Growth-Focused Strategy
The company plans to utilise IPO funds strategically to strengthen operations and expand its healthcare footprint.
✅ Key Objectives Include:
- Part payment for Ashwini Medical Centre
- Increasing stake in Harmony Medicare Private Limited (Bharuch)
- Acquisition of Parekhs Hospital Pvt. Ltd., Ahmedabad
- Setting up a women-exclusive healthcare hospital in Vadodara
- Purchase of advanced robotic surgical equipment
- Repayment/prepayment of existing borrowings
- Funding future inorganic acquisitions
- General corporate purposes
👉 This diversified fund allocation reflects a long-term expansion and modernization strategy.
Business Overview: Gujarat Kidney and Super Speciality Hospital
Gujarat Kidney and Super Speciality Hospital is a well-established super speciality healthcare provider based in Vadodara, Gujarat.
🏥 Core Specialisations:
- Nephrology
- Urology
- Renal Transplantation
🩺 Other Medical Services:
- Cardiology
- Neurology
- Oncology
- Gastroenterology
- Orthopaedics
- General Medicine & Surgery
The hospital combines advanced medical technology, experienced doctors, and multi-disciplinary care, positioning itself strongly in India’s growing healthcare sector.
Why Investors Are Watching This IPO Closely
✔ Rising retail demand
✔ Healthcare sector growth in India
✔ Expansion through acquisitions
✔ Focus on advanced medical technology
✔ Women-centric healthcare initiative
With increasing healthcare needs and rising demand for super speciality hospitals, Gujarat Kidney and Super Speciality Hospital operates in a high-growth and defensive sector.
Should You Invest in Gujarat Kidney and Super Speciality IPO?
This IPO may appeal to:
- Long-term investors looking at healthcare growth
- Retail investors seeking exposure to hospital infrastructure
- Investors interested in moderate listing gains with stable fundamentals
However, investors should also consider:
- QIB participation
- Company financials
- Valuation at upper price band
- Overall market conditions
📌 Always consult a financial advisor before investing.
Final Thoughts
The Gujarat Kidney and Super Speciality IPO Day 3 update shows encouraging subscription trends, especially from retail investors. With a clear growth roadmap, healthcare sector tailwinds, and positive market buzz, this IPO has successfully captured investor attention.
👉 Stay tuned to our website for IPO reviews, GMP updates, subscription alerts, and stock market insights to make smarter investment decisions.
Disclaimer:
The investments & trading ideas recommended in the market analysis, research reports, etc. may not be suitable for all investors. This article or data points does not construe investment advice as stock market investments are subject to market risks so please refer to your financial consultant advice before Investing or trading. All information is a point of view, and is for educational, Learning and informational use only. The author or the group admin accepts no liability for any interpretation of articles or comments on this platform being used for actual investments. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Investors must make their own investment decisions based on their specific investment objectives, goals and financial position only after consulting with registered market intermediaries.